Lindbrook Capital’s Viemed Healthcare VMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$844 Hold
116
﹤0.01% 2512
2024
Q4
$930 Hold
116
﹤0.01% 2495
2024
Q3
$850 Hold
116
﹤0.01% 2537
2024
Q2
$760 Hold
116
﹤0.01% 2532
2024
Q1
$1.09K Hold
116
﹤0.01% 2401
2023
Q4
$911 Hold
116
﹤0.01% 2484
2023
Q3
$781 Hold
116
﹤0.01% 2427
2023
Q2
$1.13K Sell
116
-8
-6% -$81 ﹤0.01% 2346
2023
Q1
$1.2K Hold
124
﹤0.01% 2414
2022
Q4
$937 Hold
124
﹤0.01% 2481
2022
Q3
$1K Hold
124
﹤0.01% 2520
2022
Q2
$1K Hold
124
﹤0.01% 2393
2022
Q1
$1K Buy
+124
New +$576 ﹤0.01% 2387
2021
Q4
Sell
-121
Closed -$1K 2213
2021
Q3
$1K Buy
+121
New +$787 ﹤0.01% 1795

Other funds holding VMD

Lindbrook Capital's VMD Position: Q1 2025 in Review

Lindbrook Capital held its Viemed Healthcare (VMD) position steady in Q1 2025 at 116 shares worth $844. The position accounts for ﹤0.01% of the portfolio, ranked #2512.

Lindbrook Capital first reported a position in VMD in Q3 2021 and has held it in 14 quarters since. The position peaked at $1.2K in Q1 2023. 139 funds tracked by Wall St. Rank hold VMD as of Q1 2025.

  • Lindbrook Capital held 116 shares of Viemed Healthcare worth $844 as of Q1 2025.
  • Lindbrook Capital left its Viemed Healthcare share count unchanged in Q1 2025.
  • Viemed Healthcare made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2512 holding.
  • Lindbrook Capital first reported a position in Viemed Healthcare in Q3 2021 and has held it in 14 quarters since.
  • Lindbrook Capital's Viemed Healthcare position peaked at $1.2K in Q1 2023.
  • 139 funds tracked by Wall St. Rank held Viemed Healthcare as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.